“…This axis has been implicated in the etiologies of diseases involving immune-associated bone loss, including rheumatoid arthritis, periodontitis, multiple myeloma, and even osteoporosis (Colucci et al, 2004;Wittrant et al, 2004;Takayanagi, 2005;Weitzmann and Pacifici, 2005;Walsh et al, 2006). RANKL enhances the survival and activity of dendritic cells and macrophages, acts as a chemotatic factor for monocytes (Breuil et al, 2003;Park et al, 2005) and regulates bone remodeling via the escalation of osteoclastogenesis and osteoclast activity (Wada et al, 2006 and references therein). OPG, a soluble decoy receptor for RANKL, regulates B cell maturation and the development of efficient antibody responses (Yun et al, 2001;Stolina et al, 2003), as well as the attenuation of bone resorption via its interfering action on RANKL (Wada et al, 2006 and references therein).…”